Mechanism-based biomarker discovery
Περίληψη σε άλλη γλώσσα
Biomarkers are cornerstones of healthcare spanning a variety of applications from disease diagnosis to stratification and prediction of likely outcome. Despite significant efforts that have identified thousands of potential biomarkers, their translation into clinical practice remains poor, averaging 1.5 per year across all diseases. This inefficiency primarily results from the lack of connection of the candidate biomarkers with the underlying pathophysiological mechanisms that they monitor which results in poor reproducibility in their developmental pipeline. On top of these limitations, the current single-biomarker-tosingle-disease approach does not capture the multifactorial nature of complex diseases like Chronic Kidney Disease (CKD). CKD is a major public health problem that affects approximately to 14% of the general population and requires asymptomatic, early-stage, and diseasespecific, biomarkers to deliver more precise diagnostic
Γλώσσα